As in two prior petitions, which the U.S. Supreme Court denied review of in 2022, Monsanto argues that federal law preempts ...
A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a CD30/CD16A bispecific antibody, was safe and generated strong response rates ...
A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results